Lb Pharmaceuticals (LBRX) Operating Leases (2024 - 2026)

Lb Pharmaceuticals' Operating Leases history runs 3 years deep, the most recent figure standing at $2.7 million for Q1 2026.

• In Q1 2026, Operating Leases changed N/A year-over-year to $2.7 million; the TTM figure through Mar 2026 stood at $2.7 million (changed N/A YoY), while the FY2025 annual figure was $2.8 million, down 11.72% from the prior year.
• Operating Leases was $2.7 million for Q1 2026 at Lb Pharmaceuticals, down from $2.8 million in the prior quarter.
• In the past five years, Operating Leases ranged from a high of $3.2 million in Q4 2024 to a low of $2.7 million in Q1 2026.
• Historically, Operating Leases has averaged $2.9 million across 3 years, with a median of $2.9 million in 2025.
• Biggest YoY gain for Operating Leases was 11.72% in 2025; the steepest drop was 11.72% in 2025.
• A 3-year view of Operating Leases shows it stood at $3.2 million in 2024, then fell by 11.72% to $2.8 million in 2025, then fell by 3.49% to $2.7 million in 2026.
• The last three Operating Leases figures came in at $2.7 million (Q1 2026), $2.8 million (Q4 2025), and $2.9 million (Q3 2025), per Business Quant data.